- You can view the full Express Scripts Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Express Scripts (ESRX) stock was rallying Friday afternoon following a bullish note at Jefferies.
Wall Street will look to comments from Fed Chair Janet Yellen on interest rates; futures are higher; Carl Icahn recently discussed selling his stake in Herbalife, a report says.
Leerink analysts say Express Scripts (ESRX) stock may be lower today as a result of Mylan's (MYL) continued EpiPen controversy.